HALOVSLEXX• 6 Months (Normalized)
HALO vs LEXX (Halozyme Therapeutics Inc. vs Lexaria Bioscience Corp.)
Showing Closing Date Range from Apr 8 to Oct 5, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
HALO Performance $109.86
+67.9%
Halozyme Therapeutics Inc.
Normalized Baseline0.00%
LEXX Performance $2.88
-79.9%
Lexaria Bioscience Corp.
Normalized Baseline0.00%
Alpha Spread Margin HALO LEADS
+147.8 pts
HALO outperforming by 147.80 percentage points
HALOLEXX
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
HALO LEXX
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(124 dates)
| Date | HALO Price | HALO Gain (%) | LEXX Price | LEXX Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $109.86 | +67.90% | $2.88 | -79.90% | +147.80% |
| Oct 01, 2026 | $106.94 | +63.44% | $- | - | |
| Sep 30, 2026 | $110.40 | +68.73% | $3.15 | -78.01% | +146.74% |
| Sep 29, 2026 | $111.56 | +70.50% | $3.13 | -78.15% | +148.65% |
| Sep 28, 2026 | $112.89 | +72.54% | $3.23 | -77.49% | +150.03% |
| Sep 25, 2026 | $113.90 | +74.08% | $3.28 | -77.10% | +151.18% |
| Sep 24, 2026 | $- | $3.37 | -76.47% | - | |
| Sep 23, 2026 | $112.44 | +71.85% | $3.24 | -77.42% | +149.27% |
| Sep 22, 2026 | $115.13 | +75.96% | $- | - | |
| Sep 21, 2026 | $111.45 | +70.33% | $3.43 | -76.09% | +146.42% |
| Sep 18, 2026 | $112.45 | +71.86% | $3.24 | -77.38% | +149.24% |
| Sep 17, 2026 | $109.68 | +67.63% | $3.29 | -77.03% | +144.66% |
| Sep 16, 2026 | $108.44 | +65.73% | $3.10 | -78.39% | +144.12% |
| Sep 15, 2026 | $106.25 | +62.39% | $3.21 | -77.59% | +139.98% |
| Sep 14, 2026 | $107.94 | +64.97% | $3.55 | -75.22% | +140.19% |
Page 1 of 9